An Israeli-founded company in Canada developing a nasal technology to treat and prevent upper respiratory and topical infections, like COVID-19, announced that its nasal spray product was approved for sale in India this month after successful Phase 3 clinical trials proved it can reduce viral load in people with mild cases of the novel coronavirus.

Read more here.